| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 503551-88-0 | 2,6-dioxaspiro[4.5]decan-9-yl methanesulfonate | | | | | |
| 503551-89-1 | 6-oxaspiro[4.5]decan-9-yl methanesulfonate | | | | | |
| 503551-90-4 | 1-oxaspiro[5.5]undecan-4-yl methanesulfonate | | | | | |
| 503551-92-6 | 1-oxa-9-thiaspiro[5.5]undecan-4-yl methanesulfonate | | | | | |
| 503551-93-7 | 2-benzyl-6-oxa-2-azaspiro[4.5]decan-9-yl methanesulfonate | | C16H23NO4S | 325.42 | | 487.2℃ at 760 mmHg |
| 503551-94-8 | 9-benzyl-1-oxa-9-azaspiro[5.5]undecan-4-yl methanesulfonate | | C17H26ClNO4S | 375.91 | | 500.5±50.0℃ at 760 mmHg |
| 503552-68-9 | (3R,4R)-3,4-二氨基吡咯烷-1-甲酸叔丁酯 | tert-butyl (3R,4R)-3,4-diaminopyrrolidine-1-carboxylate | C9H19N3O2 | 201.27 | | 292.2±40.0 °C(Predicted) |
| 503555-23-5 | 5-溴-2-氯苯甲酸叔丁酯 | tert-Butyl 5-bromo-2-chlorobenzoate | C11H12BrClO2 | 291.57 | | |
| 503555-50-8 | 6-氯-4-甲基吡啶-3-羧酸 | 6-chloro-4-methylnicotinic acid | C7H6ClNO2 | 171.58 | | |
| 503555-55-3 | 8-(5-氯-2-(4-甲基哌嗪-1-基)异烟酰胺基)-1-(4-氟苯基)-4,5，二氢-1h-苯并[g]吲唑-3-甲酰胺 | pha-408 | | | | |
| 503555-96-2 | 5-(boc-氨基)-2-氯苯甲酸 | 5-(boc-amino)-2-chlorobenzoic acid | C12H14ClNO4 | 271.7 | | |
| 503559-76-0 | (e)-4-(2-(苄氧基)-4-氟苯基)-2,6-二异丙基-5-(丙-1-烯-1-基)烟酸甲酯 | (e)-methyl 4-(2-(benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-enyl)nicotinate | | | | |
| 503559-80-6 | 4-[4-氟-2-(苯基甲氧基)苯基]-2,6-双(1-甲基乙基)-5-(1-丙烯-1-基)-3-吡啶甲醛 | 4-[4-fluoro-2-(phenylmethoxy)phenyl]-2,6-bis(1-methylethyl)-5-(1-propen-1-yl)-3-pyridinecarboxaldehyde | | | | |
| 503559-84-0 | | glucagon receptor antagonists-1 | C29H34FNO2 | 447.58 | | |
| 50356-03-1 | | lithium tert-butylcyclopentadienide | | | 273-277℃ | |
| 503561-02-2 | (2S)-2-(4-methoxyphenyl)piperidine | | C12H17NO | 191.274 | | |
| 503564-50-9 | | 3,3,4,4,5,5,6,6-nonafluorohexylphosphonic acid | | | | |
| 503568-73-8 | 5-(1-甲基环丙基)-1H-吡唑-3-胺 | 5-(1-Methylcyclopropyl)-1H-pyrazol-3-amine | C7H11N3 | 137.18 | | |
| 50357-25-0 | 2-氨基-2-(2-硝基苯基)乙酸盐酸盐 | 2-amino-2-(2-nitrophenyl)acetic acid hydrochloride | | | | |
| 50357-45-4 | | 4,4'-(pentamethylenedioxy)di-benzamidin dihydrochloride | C19H26Cl2N4O2 | 413.34 | | |
| 50358-35-5 | 5-氨基-6-甲基喹啉 | 5-amino-6-methylquinoline | C10H10N2 | 158.2 | 133-137 °C | 326.2±27.0 °C(Predicted) |
| 50358-37-7 | 6-氯-8-甲基喹啉-5-胺 | 6-Chloro-8-methylquinolin-5-amine | C10H9N2Cl | 192.64 | | |
| 50358-38-8 | | 6-methoxyquinolin-5-amine | C10H10N2O | 174.20 | 154-156 °C | 341.1±27.0 °C(Predicted) |
| 50358-39-9 | 5-氨基-6-溴喹啉 | 6-Bromoquinolin-5-amine | C9H7BrN2 | 223.0693 | | |
| 50358-40-2 | | 8-methyl-quinolin-5-ylamine | C10H10N2 | 158.1998 | | |
| 50358-42-4 | 6-氨基-5-溴喹啉 | 6-amino-5-bromoquinoline | C9H7BrN2 | 223.0693 | | |
| 50358-62-8 | 6-氨基-8氯喹啉 | 8-chloroquinolin-6-amine | C9H7ClN2 | 178.62 | | 364.6±22.0°C at 760 mmHg |
| 50358-63-9 | 6-氨基-5-溴喹喔啉 | 6-amino-5-bromoquinoxaline | C8H6BrN3 | 224.07 | 157°C | 367ºC at 760 mmHg |
| 503596-11-0 | 3-(邻-甲苯基)-[1,2,4]三唑并[3,4-b][1,3,4]噻二唑-6-胺 | 3-(o-tolyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine | | | | |
| 503596-47-2 | (三苯甲基)亚硫酰亚胺 | (triphenylmethyl)thionyl imide | C19H15NOS | 305.4 | | |
| 503598-40-1 | 咪达那新杂质6 | imidafenacin impurity 6 | | | | |
| 503598-68-3 | 咪达那新杂质2 | imidafenacin impurity 2 | | | | |
| 5036-02-2 | | 2,3,5,6-tetrahydro-6-phenyl-1-b]thiazol (+/-)-imidazo[ | | | | |
| 5036-03-3 | | 1-(2-hydroxyethyl)-3-((5-nitrofurfurylidene)amino)-2-imidazolidinon | C10H12N4O5 | 268.22 | | |
| 5036-48-6 | N-(3-氨丙基)咪唑 | 1H-Imidazole-1-propanamine | C6H11N3 | 125.17 | -68 °C | 296 °C |
| 5036-49-7 | | 3-(5-methyl-pyrazol-1-yl)-propylamine | | | | |
| 5036-85-1 | 2-甲基苯并[d]噻唑-4-磺酰氯 | 2-Methylbenzo[d]thiazole-4-sulfonyl chloride | C8H6ClNO2S2 | 247.72 | | |
| 5036-87-3 | 2-甲基苯并[d]噻唑-7-胺 | 2-Methylbenzo[d]thiazol-7-amine | | | | |
| 503601-25-0 | | 2-morpholineacetic acid ethyl ester hcl | C8H16ClNO3 | 209.67 | | |
| 50361-05-2 | | (E)-(2-Chloroethenyl)arsinous dichloride | C2H2AsCl3 | 207.32 | | |
| 503610-43-3 | 瑞舒伐他汀ep杂质d | rosuvastatin ep impurity d | C22H26FN3O5S | 463.52 | 131℃ | 695.0±65.0℃(Predicted) |
| 503610-44-4 | (瑞舒伐他汀酰基)-β-d-葡糖苷酸 | | | | | |
| 503612-47-3 | 4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1 | apixaban | C25H25N5O4 | 459.5 | | |
| 503612-76-8 | 阿哌沙班杂质28 | apixaban impurity 28 | C24H23N5O4 | 445.47 | | |
| 503614-56-0 | 1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氢-1h-吡唑并[3,4-c]吡啶-3-羧酸乙酯 | ethyl 1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate | C16H17N3O4 | 315.32 | | 588.554°C at 760 mmHg |
| 503614-91-3 | 4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1h-吡唑并[3,4-c]吡啶-3-羧酸乙酯 | ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate | C27H28N4O5 | 488.54 | | 758.7±60.0°C at 760 mmHg |
| 503614-92-4 | 1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代哌啶-1-基)苯基]-4,5,6,7-四氢-1h-吡唑并[3,4-c]吡啶-3-羧酸 | 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylic acid | C25H24N4O5 | 460.48 | | 807.2±65.0°C at 760 mmHg |
| 503615-03-0 | 5,6-二氢-3-(4-吗啉基)-1-(4-硝基苯基)-2(1h)-吡啶酮 | 3-morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1h)-one | C15H17N3O4 | 303.31 | | 506.532°C |
| 503615-07-4 | 6-(4-氨基苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氢-1h-吡唑并[3,4-c]吡啶-3-羧酸乙酯(阿哌沙班中间体) | ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate | C22H22N4O4 | 406.43 | | |
| 50362-93-1 | 2-吡啶-3-基-1H-喹唑啉-4-酮 | 2-(Pyridin-3-yl)quinazolin-4(1H)-one | C13H9N3O | 223.23 | | |
m.cnreagent.com